Integration of Immunotherapy Into Adjuvant Therapy for Resected NSCLC: ALCHEMIST Chemo-IO (ACCIO) (opens in a new tab)
RecruitingPhase 3
Carcinoma, Non-Small-Cell LungCarcinoma, BronchogenicCarboplatinCisplatinGemcitabine Hydrochloride
Dr. Sunitha Vemulapalli, MD
NPI1134113012PAC ID9830170380
- Medicare services, 2024
- 1,151
- Medicare patients, 2024
- 350
- Part D claims, 2024
- 4,673
- Clinical trials
- 12
- MIPS score, 2024
- 88
- Practice address
- 2600 6th St SW, Canton, OH 44710
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Aultman Hospital - HOPD
Childrens Hospital outpatient department · Canton, Ohio
Find Dr. Vemulapalli's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Sunitha Vemulapalli is a hematologist and oncologist in Canton, Ohio
Dr. Vemulapalli practices at Aultman Hospital - HOPD in Canton, Ohio.
Dr. Vemulapalli's NPI, 1134113012, was assigned on September 7, 2005. Dr. Vemulapalli holds Ohio license 35084262.
NPI and contact details
- NPI
- 1134113012NPI Registry (opens in a new tab)
- Medicare PAC ID
- 9830170380
- NPI enumeration date
- September 7, 2005
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 57
- Medical school graduation
- 1995
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Sunitha Vemulapalli practices at Aultman Hospital - HOPD in Canton, Ohio
Dr. Vemulapalli's primary practice is Aultman Hospital - HOPD, at 2600 6th St SW, Canton, OH 44710.
- Aultman Hospital - HOPD2600 6th St SW, Canton, OH 44710
Source: Dmand AI Affiliation Data
Dr. Sunitha Vemulapalli is affiliated with 5 sites of care and 2 medical groups
Dr. Vemulapalli's primary practice is Aultman Hospital - HOPD in Canton, Ohio. Dr. Vemulapalli is also affiliated with Aultman Hospital. The medical group on file is Aultman Hospital. Dmand AI also links Dr. Vemulapalli to 3 more hospitals and 1 medical group, each named with a free account.
Aultman Hospital - HOPDPrimary
Source: Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Sunitha Vemulapalli's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vemulapalli practices, 5 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Aultman Hospital - HOPD | Available with a free account |
| +4 more sites and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Vemulapalli practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Sunitha Vemulapalli is one of 460 hematologists and oncologists in Ohio
Hematology and oncology is Dr. Vemulapalli's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Vemulapalli is licensed in Ohio.
Specialties and state licenses
- Hematology and oncology, OhioPrimary
Hematologists and oncologists near Dr. Vemulapalli
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
460hematologists and oncologists in Ohio
6hematologists and oncologists in Canton
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Sunitha Vemulapalli billed Medicare for 1,151 services in 2024
CMS data shows 1,151 Medicare services from Dr. Vemulapalli across 5 procedure codes in 2024, for 350 Medicare patients. Medicare paid $80,748 for them. Every service was in a facility, such as a hospital, rather than an office.
Medicare services, 20241,151
Medicare patients350
Paid by Medicare$80,748
Procedure codes5
Dr. Vemulapalli's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 1,2652024: 1,1519%
Dr. Vemulapalli compared with the Ohio median for hematologists and oncologists, 2024
- Dr. Vemulapalli
- Ohio median
- Medicare services
- 1,151vs 62684% above
- Medicare patients
- 350vs 23450% above
- Part D claims
- 4,430vs 4789.3 times
Medians across 452 hematologists and oncologists in Ohio with Dmand AI profiles that report each measure.
Dr. Vemulapalli's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Vemulapalli?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Vemulapalli and other hematologists and oncologists in Ohio.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Sunitha Vemulapalli treated 350 Medicare patients in 2024, average age 74
CMS counts 350 Medicare patients who saw Dr. Vemulapalli in 2024. The largest group is 65 to 74, with 159 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Vemulapalli's median patient age at 69, with 78% women.
Medicare patients, 2024350
Average age74
Average risk score1.79
Also on Medicaid11%
Dr. Vemulapalli's Medicare patients by age, 2024
Dr. Vemulapalli's Medicare patients by sex, 2024
- Women26074%
- Men9026%
Chronic conditions among Dr. Vemulapalli's Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Cancer65%
- Arthritis56%
- Anxiety40%
- Diabetes31%
- Ischemic heart disease31%
- Chronic kidney disease30%
Share of Medicare patients with each condition. A patient can have several.
Dr. Vemulapalli's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 69
Patient panel by sex, all payers
- Women78%
- Men21%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Sunitha Vemulapalli wrote 4,673 Medicare Part D claims in 2024
In 2024, Dr. Vemulapalli wrote 4,673 Medicare Part D claims for 694 patients. 81% of them were for generic drugs. CMS names the drug for 4,430 of them, across 52 drugs with 11 or more claims each, at $8,321,323 in total drug cost. In 2023, CMS named 3,633 claims across 49 drugs.
Part D claims, 20244,673
Drugs named by CMS52
Total drug cost$8.3M
Part D patients694
Dr. Vemulapalli's Part D claims by kind of drug, 2024
- Generic3,782 claims81%
- Brand-name891 claims19%
Dr. Vemulapalli's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Vemulapalli's Part D claims, 2024
- Opioids2%115 of 4,673 claims
- Antibiotics2%76 of 4,673 claims
- Antipsychotics, patients 65 and over0%15 of 4,673 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 3,6332024: 4,43022%
Drugs named by CMS: 52 in 2024, 49 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Sunitha Vemulapalli scored 88 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Vemulapalli for performance year 2024, reported as part of a group. Dr. Vemulapalli accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Dr. Vemulapalli's MIPS scores, performance year 2024
- 88of 100Final score
- 77.5of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 75of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Find hematologists and oncologists like Dr. Vemulapalli by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Sunitha Vemulapalli has worked on 12 clinical trials
Dmand AI links Dr. Vemulapalli to 12 clinical trials, 5 of them phase 3 studies. 10 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Carcinoma, Bronchogenic and Breast Carcinoma In Situ. National Cancer Institute (NCI) sponsors the most, 9. Open Payments lists research payments to Dr. Vemulapalli that name 2 trials.
Clinical trials with Dr. Vemulapalli by phase
- NonePhase 1: no trials
- 4Phase 2: 4 trials
- 5Phase 3: 5 trials
- NonePhase 4: no trials
Conditions in Dr. Vemulapalli's trials
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Bronchogenic
- Breast Carcinoma In Situ
- Breast Neoplasms
- Breast Diseases
Investigators on the most trials with Dr. Vemulapalli
- Rajesh Bajaj, MD6 shared trials
- Christopher Haekang Chay, MD6 shared trials
- John J. Inzerillo, MD6 shared trials
Recent clinical trials with Dr. Vemulapalli
Small Cell Lung CarcinomaCarcinoma, BronchogenicCarboplatinCisplatinEtoposide
Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung Cancer (opens in a new tab)
Active, not recruitingPhase 2
Lung NeoplasmsThoracic NeoplasmsNivolumabCabozantinib S-malateDocetaxel
Adenocarcinoma of LungCarcinoma, Non-Small-Cell LungRucaparib
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair (opens in a new tab)
Active, not recruitingPhase 3
Colorectal Neoplasms, Hereditary NonpolyposisDNA Repair-Deficiency DisordersAtezolizumabFluorouracilLeucovorin Calcium
Sources: ClinicalTrials.gov (National Library of Medicine); and Dmand AI Research Linkage
Dr. Sunitha Vemulapalli received $9,063 in industry payments from 2016 to 2025
CMS Open Payments shows 391 general payments to Dr. Vemulapalli from 54 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 76% of the total. Bristol-Myers Squibb Company paid the most, $1,724. It also lists 3 research payments totaling $3,144 from 2022 to 2024, naming 2 clinical trials.
General payments to Dr. Vemulapalli by program year, 2016 to 2025
General payments to Dr. Vemulapalli by kind, 2016 to 2025
$9.1Kin total
- Food and beverage$6,91976%
- Consulting fees$1,86021%
- Education$2843%
Companies that paid Dr. Vemulapalli the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Sunitha Vemulapalli's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Clinical trials and co-investigators | ClinicalTrials.gov (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Sunitha Vemulapalli
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Sunitha Vemulapalli's NPI number?
Dr. Sunitha Vemulapalli's NPI number is 1134113012. It was assigned on September 7, 2005, and it is active in the NPI Registry.
What kind of doctor is Dr. Sunitha Vemulapalli?
Dr. Sunitha Vemulapalli is a hematologist and oncologist in Canton, Ohio. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Sunitha Vemulapalli practice?
Dr. Vemulapalli practices at 2600 6th St SW, Canton, OH 44710. Dr. Vemulapalli's primary practice is Aultman Hospital - HOPD in Canton, Ohio. Dmand AI also links Dr. Vemulapalli to 3 hospitals and 1 medical group.
What is Dr. Sunitha Vemulapalli's medical license number?
Dr. Vemulapalli holds Ohio license 35084262.
Which hospitals is Dr. Sunitha Vemulapalli affiliated with?
Dr. Vemulapalli is affiliated with Aultman Hospital. Dmand AI links Dr. Vemulapalli to 3 more hospitals.
What medical group is Dr. Sunitha Vemulapalli part of?
Dr. Vemulapalli is linked to Aultman Hospital. Dmand AI links Dr. Vemulapalli to 1 more medical group.
Does Dr. Sunitha Vemulapalli accept Medicare?
Yes. CMS data shows Dr. Vemulapalli billed Medicare for 1,151 services in 2024, and Dr. Vemulapalli accepts Medicare assignment.
What is Dr. Sunitha Vemulapalli's MIPS score?
Dr. Vemulapalli's MIPS final score for performance year 2024 is 88 out of 100, reported as part of a group.
How many Medicare patients does Dr. Sunitha Vemulapalli see?
CMS counts 350 Medicare patients who saw Dr. Vemulapalli in 2024, with an average age of 74.
What services does Dr. Sunitha Vemulapalli bill to Medicare?
In 2024, Dr. Vemulapalli's most billed Medicare services were office visit, established patient (99214), hospital inpatient care (99232) and hospital inpatient care (99222).
Show 4 more questionsShow fewer questions
What drugs does Dr. Sunitha Vemulapalli prescribe most?
In 2024 Medicare Part D data, Dr. Vemulapalli's most prescribed drugs by claims were Anastrozole, Alendronate Sodium and Exemestane.
Has Dr. Sunitha Vemulapalli received payments from drug or device companies?
CMS Open Payments shows $9,063 in general payments to Dr. Vemulapalli from 54 companies from 2016 to 2025. The largest total came from Bristol-Myers Squibb Company.
How long has Dr. Sunitha Vemulapalli been practicing?
Dr. Vemulapalli graduated from medical school in 1995, 31 years ago.
Does Dr. Sunitha Vemulapalli do research?
Dr. Vemulapalli has worked on 12 clinical trials.
Selling to hematology and oncology practices?
See hematologists and oncologists in Ohio by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card